Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Initiation of process for capital increase to take advantage of new growth opportunities, updated financial calendar

Facing major new commercial opportunities in the vertical farming and UV-C disinfection markets while at the same time anticipating funding needs for production capacity, spin-offs and continued corona-related uncertainty, LED iBond’s Board of Directors finds it commercially prudent to initiate a process for a capital increase to further strengthen the company’s capital base.Aiming for substantial international growth in coming years, LED iBond International A/S (LED iBond, the “Company”) completed an initial public offering in June 2020 to strengthen the Company’s balance sheet for the

Voluntary withdrawal of Imfinzi indication in advanced bladder cancer in the US

22 February 2021 07:00 GMT Voluntary withdrawal of Imfinzi indicationin advanced bladder cancer in the US AstraZeneca today announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer. This decision was made in consultation with the Food and Drug Administration (FDA). In May 2017, Imfinzi was granted accelerated approval in the US based on promising tumour response rates and duration of response data from Study 1108, a Phase I/II trial that evaluated the safety and

Össur hf: Final agenda and proposals for the Annual General Meeting 8 March 2021

Announcement no. 05/2021 22 February 2021  Össur hf: Final agenda and proposals for the Annual General Meeting 8 March 2021 Enclosed is the final agenda and proposals for Össur hf.'s Annual General Meeting to be held on Monday 8 March 2021 at 9:00 am (GMT). The Annual General Meeting will be fully virtual as previously announced. No changes have been made to the previously announced agenda and proposals. Further information Investor Relations, IR@ossur.com, +354 515 1300 Össur press releases by e-mail If you wish to receive Össur press releases by e-mail, please

Diaprost Announces Promising New Study for Patients with Metastatic PCa

Diaprost announced today a publication in the journal of Clinical Cancer Research on PSA-targeted Alpha-, Beta- and Positron Emitting Immuno-Theranostics in Murine Prostate Cancer Models and Non-Human Primates.The extensive preclinical study was conducted at Memorial Sloan Kettering Cancer Center (MSK) on Diaprost’s propriety antibody (hu5A10) targeting PSA. This rigorous preclinical evaluation of radiolabeled hu5A10-based compounds in prostate cancer (PCa) mouse models and non-human primates, establishes hu5A10 as a promising theranostic (therapy and diagnostic) agent that allows specific

Scout Gaming signs agreement with ATG

Scout Gaming has entered into an agreement with AB Trav & Galopp, ATG (the Swedish Horse Racing Totalisator Board), Sweden’s largest gaming operator measured by turnover.The companies have agreed to jointly launch Scout Gaming's award-winning DFS product on ATG.se with a soft launch aimed at the second quarter 2021, followed by a wider marketing push in the third quarter, in time for the start of English Premier League and other major European sport leagues. ATG is owned by the Swedish trotting and thoroughbred associations and was the exclusive provider of horse betting on the Swedish

Genova considers issuance of green capital securities and redemption of preference shares

Genova Property Group AB (publ) (the “Issuer” or “Genova”) has mandated ABG Sundal Collier AB (“ABG Sundal Collier”) and Swedbank AB (publ) (“Swedbank”) as joint bookrunners to arrange fixed income investor meetings commencing on 24 February 2021, to investigate the possibility to issue new subordinated perpetual floating rate callable green capital securities in the amount up to SEK 700m, under a framework of SEK 1,250m (“New Capital Securities”). A capital market transaction may follow, subject to, inter alia, market conditions. The Green Finance Framework has been established in

Tokmanni Group Corporation: Notice of Annual General Meeting 2021

Tokmanni Group Corporation        Stock exchange release        22 February 2021 at 9:00 a.m.The shareholders of Tokmanni Group Corporation are hereby invited to the Annual General Meeting to be held on Tuesday 23 March 2021 at 10:00 a.m. at Tokmanni’s administration and logistics centre at the address Isolammintie 1, 04600 Mäntsälä, Finland. It will not be possible to participate in the meeting at the meeting venue, but participation will take place in advance in the manner described in this notice. The Board of Directors of the Company has resolved on exceptional meeting procedures

The board of directors of Scandi Standard has resolved on acquisitions of own shares

The board of directors of Scandi Standard AB (publ) has, based on the authorisation from the annual general meeting 2020, resolved that the company may acquire a maximum of 540,000 own shares on Nasdaq Stockholm. The purpose of acquisitions of own shares shall be to secure delivery of shares to the participants in LTIP 2020 or to hedge costs related to LTIP 2020.Terms and conditions for acquisitions of own sharesAccording to the board of directors’ resolution, any acquisitions of own shares shall be made on Nasdaq Stockholm in accordance with Nasdaq Stockholm’s Rule Book for Issuers and

Elekta establishes office in Egypt to meet growing need for precision radiation medicine

Demand for healthcare services and technology presents strong growth potentialSTOCKHOLM, February 22, 2021 – Elekta (EKTA-B.ST) announced today that it will establish a permanent office in Cairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders. To strengthen its market leadership and continue providing excellent service to the installed base of more than 40 Elekta radiotherapy solutions, Elekta has signed an agreement to acquire the oncology division of its previous distributor,

Catella advises the Danish state-owned national train service operator DSB in a joint venture development project with Danica

DSB and Danica Pension has formed a joint venture to undertake a 25,000 square meter development project with prime location in the inner city of Copenhagen next to the Central Train Station and Tivoli Gardens.As one of Denmark’s largest landowners, the state-owned national train service operator DSB has adopted a strategy to undertake redevelopment of its real estate portfolio together with experienced joint venture partners. DSB retained Catella Corporate Finance as exclusive financial advisor to prepare business plans, structure joint venture terms and to identify a joint venture

Observe Medical ASA : Invitation to fourth quarter 2020 presentation

Observe Medical ASA invites you to a presentation of the fourth quarter 2020 on Tuesday February 23 at 8.30 CET. Due to the covid-19 situation the presentation will only be held as a webcast. The event will start at 08.30 CET and will be webcasted on www.observemedical.com - Investor relations and on the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210223_2/ Representatives from the Company will be: CEO Björn Larsson and CFO Per Arne Nygård. Viewers are welcome to ask written questions during and after the presentation through the webcast player.

Saab Delivers Third GlobalEye

Saab delivered the third GlobalEye aircraft to the United Arab Emirates on 20 February 2021.This follows Saab’s previous deliveries of GlobalEye in April and September 2020. The United Arab Emirates has ordered a total of five GlobalEye aircraft. “Completing three deliveries of a solution as advanced as GlobalEye in less than a year proves Saab’s solid expertise as a provider of high-technology solutions and our focus on meeting our commitments, especially given the current circumstances. By handling the entire process, including sensor development and integration, we are uniquely in

Axactor SE – Preliminary result of the subsequent offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Oslo, Norway – 19 February 2021 Reference is made to previous announcements by Axactor SE ("Axactor" or the "Company", OSE ticker code "ACR") regarding a subsequent offering of up to 26,750,000 new shares in the Company (the "Offer Shares") at a subscription price of

Primary insider disclosure

The following primary insiders (or their related parties as described below) have, as part of the company's incentive program, committed to acquire shares in Ocean Yield ASA (the "Company" or "Ocean Yield"): · Lars Solbakken, CEO, has through his wholly owned company Finmarine AS acquired 52,000 shares in Ocean Yield. Upon completion of such acquisition, Lars Solbakken will own, directly or indirectly, 1,752,880 shares in the Company. ·  Eirik Eide, CFO, has through his wholly owned company Kleiver Invest AS acquired 30,000 shares in Ocean Yield. Upon completion of such acquisition,

Report from the annual general meeting in Desenio Group AB (Publ) on 19 february 2021

The following resolutions, among others, were passed at the annual general meeting of shareholders (the “Meeting”) and subsequent statutory board meeting of Desenio Group AB (publ) (the “Company”) held today, 19 February 2021.Adoption of income statements and balance sheetsThe Meeting adopted the income statement and balance sheet for the Company as well as the consolidated income statement and consolidated balance sheet. Allocation of profitThe Meeting resolved to distribute a dividend in the amount of SEK 285,053,231.65 to be allotted pro rata to the total number of shares in the

Desenio publishes 2020 Annual report

Desenio Group AB (publ) publishes the Group’s annual report on the Group’s website as of today.Desenio Group AB has published the Annual Report 2020 (in Swedish) on deseniogroup.com.   About Desenio Desenio is a Swedish, fast growing digital direct-to consumer company with a leading position as an online based provider of affordable wall art in Europe. The Company offers its customers a unique and curated assortment of over 6,000 designs as well as frames and accessories in 35 countries via 20 local websites. Leveraging a data-driven strategy both for the creation of art and for

Autoliv Board of Directors approves renewal of EMTN Programme

(Stockholm, Sweden, February 19, 2021) – The Funding Committee of the Board of Directors of Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb) (the “Company”) approved today the renewal for one year of its €3,000,000,000 guaranteed euro medium term note programme (the “EMTN Programme”), which was originally established on April 11, 2019.The renewal of the EMTN Programme will allow the Company to take advantage of the funding opportunities provided by the capital markets and institutional investors through the future issuance of notes (the “Notes”). The Notes issued by the Company under the EMTN

Storebrand ASA - Status share buy back to fund employee incentive program

Storebrand ASA has on 19 February purchased 300,000 own shares at an average price of NOK 72.35 per share. After this transaction Storebrand owns a total of 2,115,955 own shares. For further information about the programme, Storebrand refers to the Oslo Stock Exchange notification made on 11 February 2021 . Lysaker, 19 February 2021 Contacts Head of Investor Relations: Sundahl, Daniel daniel.sundahl@storebrand.no or (+47) 913 61 899 Storebrand's ambition is to provide our customers with financial freedom and security by being the best

Finnair Plc – Acquisition of own shares on 19 Feb 2021

FINNAIR PLC STOCK EXCHANGE RELEASE 19.02.2021 At Nasdaq Helsinki Ltd: Date  19.02.2021Exchange transaction  BuyShare trading code  FIA1SAmount, shares   1,000,000Total cost, EUR  629,000.00Average price/share, EUR  0.6290Highest price/share, EUR  0.6415Lowest price/share, EUR  0.6140  The company holds a total of 1,170,660 of its own shares (FIA1S) including the shares acquired on 19 Feb 2021. Detailed information concerning the acquisition is attached to this stock exchange release.On behalf of Finnair

Repurchase of own shares

TietoEVRY Corporation    Stock Exchange Release   19 February 2021 18.30 EET                       Date:                                   19 February 2021 Exchange transaction:        Buy                       Share class                        TIETO Amount, shares                  75 000 Average price/share, EUR 27.2164 Total price, EUR                 2 041 230.00                       The number of shares held by TietoEVRY Corporation after the completion of transactions: 105 978 shares.                       On behalf of TietoEVRY Corporation

Veoneer publishes 2020 Annual Report on Form 10-K

Stockholm, Sweden, February 19, 2021: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), has filed its 2020 Annual Report on Form 10-K with the Securities and Exchange Commission (SEC).The 2020 Annual Report on Form 10-K is available at the SEC Edgar website: www.sec.gov and on Veoneer’s web site veoneer.com.Veoneer has also published its 2020 Sustainability Report on Veoneer’s web site veoneer.com For more information please contact:Thomas Jönsson, EVP Communications & IR, thomas.jonsson@veoneer.com, tel +46 (0)8 527 762 27 Veoneer, Inc. is a worldwide

Konecranes Plc - Managers' transactions - Topi Tiitola

Konecranes Plc - Managers' transactions - Topi Tiitola____________________________________________ Person subject to the notification requirementName: Tiitola, TopiPosition: Other senior managerIssuer: Konecranes PlcLEI: 549300EF0CDEQZBMA096 Notification type: INITIAL NOTIFICATIONReference number: 549300EF0CDEQZBMA096_20210219145011_210____________________________________________ Transaction date: 2021-02-18Venue: XHELInstrument type: SHAREISIN: FI0009005870Nature of the transaction: ACQUISITION Transaction details(1): Volume: 36 Unit price: 36.5574 EUR

Konecranes Plc - Managers' transactions - Juha Pankakoski

Konecranes Plc - Managers' transactions - Juha Pankakoski____________________________________________ Person subject to the notification requirementName: Pankakoski, JuhaPosition: Other senior managerIssuer: Konecranes PlcLEI: 549300EF0CDEQZBMA096 Notification type: INITIAL NOTIFICATIONReference number: 549300EF0CDEQZBMA096_20210219145010_209____________________________________________ Transaction date: 2021-02-18Venue: XHELInstrument type: SHAREISIN: FI0009005870Nature of the transaction: ACQUISITION Transaction details(1): Volume: 59 Unit price: 36.5574

Plasma oxalate and kidney function are correlated in patients with primary hyperoxaluria with maintained kidney function – Data from three placebo‑controlled studies published

Stockholm – 19 February 2021. OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces the publication of an article in Pediatric Nephrology, on the significant correlation between plasma oxalate and kidney function in three controlled clinical trials with PH patients.Primary hyperoxaluria is a rare autosomal recessive inherited disorder of glyoxylate metabolism that causes an endogenous overproduction of oxalate. Oxalate cannot be degraded in humans and is mostly eliminated by the kidneys. The oxalate

There are no items matching the current filter
There are no more items matching the current filter
Back to top